Combinatorial Optimization in Rapidly Mutating Drug-Resistant Viruses

Resistance to chemicals is a common current problem in many pests and pathogens that formerly were controlled by chemicals. An extreme case occurs in rapidly mutating viruses such as Human Immunodeficiency Virus (HIV), where the emergence of selective drug resistance within an individual patient may become an important factor in treatment choice. The HIV patient subpopulation that already has experienced at least one treatment failure due to drug resistance is considered more challenging to treat because the treatment options have been reduced. A triply nested combinatorial optimization problem occurs in computational attempts to optimize HIV patient treatment protocol (drug regimen) with respect to drug resistance, given a set of HIV genetic sequences from the patient. In this paper the optimization problem is characterized, and the objects involved are represented computationally. An implemented branch-and-bound algorithm that computes a solution to the problem is described and proved correct. Data shown includes empirical timing results on representative patient data, example clinical output, and summary statistics from an initial small-scale human clinical trial.

[1]  Richard H. Lathrop,et al.  Knowledge-Based Avoidance of Drug-Resistant HIV Mutants , 1998, AI Mag..

[2]  J. Condra,et al.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.

[3]  Yuval Shahar,et al.  Synthesis of Research: EON: A Component-Based Approach to Automation of Protocol-Directed Therapy , 1996, J. Am. Medical Informatics Assoc..

[4]  Amanda G. Fisher,et al.  A molecular clone of HTLV-III with biological activity , 1985, Nature.

[5]  M Giacomini,et al.  A qualitative process theory based model of the HIV-1 virus-cell interaction. , 1994, Computer methods and programs in biomedicine.

[6]  M J Pazzani,et al.  Application of an expert system in the management of HIV-infected patients. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[7]  David S. Goodsell,et al.  Computational Coevolution of Antiviral Drug Resistance , 1997, Artificial Life.

[8]  L D Xu,et al.  An integrated rule- and case-based approach to AIDS initial assessment. , 1996, International journal of bio-medical computing.

[9]  Michael J. Pazzani,et al.  CTSHIV: a knowledge-based system for the management of HIV-infected patients , 1997, Proceedings Intelligent Information Systems. IIS'97.

[10]  M Sobesky,et al.  Decision making system. , 1994, Journal of clinical computing.

[11]  C A Kulikowski,et al.  An Architecture for Knowledge-based Construction of Decision Models , 1994, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  Bruce G. Buchanan,et al.  The MYCIN Experiments of the Stanford Heuristic Programming Project , 1985 .

[13]  L W Diamond,et al.  An expert system for the interpretation of flow cytometric immunophenotyping data. , 1994, Journal of clinical computing.

[14]  C. Birch,et al.  Reverse transcriptase mutations in sequential HIV‐1 isolates in a patient with AIDS , 1995, Journal of medical virology.

[15]  B. Larder,et al.  Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Hans B. Sieburg,et al.  Methods in the Virtual Wetlab I: rule-based reasoning driven by nearest-neighbor lattice dynamics , 1994, Artif. Intell. Medicine.

[17]  Lawrence M. Fagan,et al.  Development of a Controlled Medical Terminology: Knowledge Acquisition and Knowledge Representation , 1995, Methods of Information in Medicine.

[18]  ศิริลักษณ์ อนนันต์ณัฐศิริ,et al.  Antiretroviral Therapy for HIV Infection in 1998 , 1998 .

[19]  J. Lange,et al.  Triple combinations: present and future. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[20]  S W Tu,et al.  AIDS2: a decision-support tool for decreasing physicians' uncertainty regarding patient eligibility for HIV treatment protocols. , 1993, Proceedings. Symposium on Computer Applications in Medical Care.

[21]  Vice President,et al.  An Introduction to Expert Systems , 1989 .

[22]  B. Larder,et al.  Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. , 1992, The Journal of infectious diseases.

[23]  Yuval Shahar,et al.  Ontology-based configuration of problem-solving methods and generation of knowledge-acquisition tools: application of PROTEGE-II to protocol-based decision support , 1995, Artif. Intell. Medicine.

[24]  M A Wainberg,et al.  Identification of novel mutations that confer drug resistance in the human immunodeficiency virus polymerase gene. , 1994, Leukemia.

[25]  Richard H. Lathrop,et al.  Application of a Genotypic Driven Rule-Based Expert Artificial Intelligence Computer System in Treatment Experienced HIV-Infected Patients , 1999 .

[26]  T. Merigan,et al.  Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy , 1996, Journal of virology.

[27]  Martin A. Nowak,et al.  The frequency of resistant mutant virus before antiviral therapy , 1998, AIDS.

[28]  D M Rind,et al.  Development of a knowledge-based electronic patient record. , 1996, M.D. computing : computers in medical practice.